Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
1.550
+0.090 (6.16%)
Apr 19, 2024, 4:00 PM EDT - Market closed

PACB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Revenue
200.52128.3130.5178.8990.8978.6393.4790.7192.7860.59
Upgrade
Revenue Growth (YoY)
56.29%-1.69%65.43%-13.20%15.60%-15.88%3.04%-2.23%53.12%115.02%
Upgrade
Cost of Revenue
147.7479.2771.6546.3356.3253.5358.8146.5539.3337.19
Upgrade
Gross Profit
52.7849.0458.8632.5734.5825.134.6644.1653.4523.4
Upgrade
Selling, General & Admin
169.82160.85124.1272.875.4963.4959.1247.7945.1938.03
Upgrade
Research & Development
187.17193112.964.1559.6362.5965.3267.6260.4448.23
Upgrade
Other Operating Expenses
15.2031.1300000-23.040
Upgrade
Operating Expenses
372.19353.85268.15136.95135.12126.08124.44115.482.5886.26
Upgrade
Operating Income
-319.41-304.82-209.29-104.39-100.55-100.99-89.78-71.24-29.13-62.85
Upgrade
Interest Expense / Income
14.3414.6912.530.272.612.422.923.232.932.83
Upgrade
Other Expense / Income
-15.59-5.2653.05-134.06-19.02-0.85-0.52-0.1-0.360.48
Upgrade
Pretax Income
-318.16-314.25-274.8729.4-84.13-102.56-92.19-74.38-31.7-66.16
Upgrade
Income Tax
-11.420-93.650000000
Upgrade
Net Income
-306.74-314.25-181.2229.4-84.13-102.56-92.19-74.38-31.7-66.16
Upgrade
Shares Outstanding (Basic)
254225204165153135106897670
Upgrade
Shares Outstanding (Diluted)
254225204175153135106897670
Upgrade
Shares Change
12.95%10.00%16.67%14.71%12.90%27.83%18.55%17.90%7.29%12.25%
Upgrade
EPS (Basic)
-1.21-1.40-0.890.18-0.55-0.76-0.87-0.83-0.42-0.94
Upgrade
EPS (Diluted)
-1.21-1.40-0.890.17-0.55-0.76-0.87-0.83-0.42-0.94
Upgrade
Free Cash Flow
-268.02-279.96-117.1118.46-81.15-68.28-77.91-76.13-50.86-53.08
Upgrade
Free Cash Flow Per Share
-1.06-1.25-0.570.11-0.53-0.51-0.74-0.85-0.67-0.75
Upgrade
Gross Margin
26.32%38.22%45.10%41.28%38.04%31.92%37.08%48.68%57.61%38.62%
Upgrade
Operating Margin
-159.29%-237.58%-160.36%-132.31%-110.62%-128.44%-96.06%-78.54%-31.40%-103.73%
Upgrade
Profit Margin
-152.97%-244.92%-138.85%37.27%-92.57%-130.44%-98.63%-81.99%-34.16%-109.19%
Upgrade
Free Cash Flow Margin
-133.66%-218.20%-89.73%23.40%-89.28%-86.85%-83.35%-83.92%-54.82%-87.59%
Upgrade
EBITDA
-277.28-282.24-250.7638.97-71.58-92.92-80.83-67.27-25.09-59.11
Upgrade
EBITDA Margin
-138.28%-219.98%-192.13%49.40%-78.75%-118.18%-86.47%-74.15%-27.05%-97.55%
Upgrade
Depreciation & Amortization
26.5317.3211.599.39.957.228.443.883.684.22
Upgrade
EBIT
-303.82-299.56-262.3429.67-81.52-100.14-89.27-71.14-28.77-63.33
Upgrade
EBIT Margin
-151.51%-233.48%-201.01%37.61%-89.69%-127.36%-95.51%-78.42%-31.01%-104.52%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).